foxo4 dri senolytic 2024 study FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation The disordered p53 transactivation domain
Description
Anecdotal evidence from user communities provides additional perspective
This was below the high-teens percentage of weigh loss previously forecast
Many patients report enhanced mental clarity and reduced fatigue after just 2-3 doses
Table 1: Recommended Dosage Modifications for Adverse Reactions* *National Cancer Institute Common Toxicity Criteria for Adverse Events version 2 (NCI CTCAE v2)
